Allergy Diagnostic Testing
J15
58 active Medicare policies list J45.998, and 13 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
J15
J6
JK
JE · Effective Sep 27, 2026
JF · Effective Sep 27, 2026
JJ · Effective Sep 27, 2026
JM · Effective Sep 27, 2026
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
J9 · Effective Oct 1, 2015
13 policies from 3 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Showing 10 of 11 · All Aetna policies
| Policy | Effective | Status of J45.998 |
|---|---|---|
| Analysis of Volatile Organic Compounds | Oct 3, 2023 | Covered |
| Bortezomib Products | Feb 2, 2024 | Covered |
| Chest Physiotherapy and Airway Clearance Devices | Mar 17, 2023 | Covered |
| Extracorporeal Immunoadsorption (Prosorba Column) | Jun 5, 2023 | Covered |
| Hair Analysis | May 5, 2023 | Covered |
| Infrared Therapy | Sep 8, 2023 |
JE · Effective Oct 1, 2015
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
J5 · Effective Mar 18, 2016
J8 · Effective Mar 18, 2016
JE · Effective Oct 1, 2015
JF · Effective Oct 1, 2015
J9 · Effective Oct 1, 2015
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
J15 · Effective Oct 1, 2015
J6 · Effective Oct 1, 2015
JK · Effective Oct 1, 2015
JE · Effective Oct 1, 2015
JF · Effective Oct 1, 2015
J9 · Effective Jul 11, 2021
JK · Effective Dec 1, 2021
JH · Effective Jul 11, 2021
JL · Effective Jul 11, 2021
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
National · Effective Sep 27, 2026
National · Effective Oct 4, 2026
National · Effective Sep 27, 2026
National · Effective Sep 27, 2026
National · Effective Sep 27, 2026
JL · Effective Oct 7, 2025
J9 · Effective Oct 7, 2025
National · Effective Oct 1, 2026
National · Effective Oct 1, 2026
National · Effective Jan 1, 2026
National · Effective Oct 1, 2026
J6 · Effective Apr 1, 2026
National · Effective Jun 4, 2026
National · Effective Oct 1, 2026
JL · Effective Jan 1, 2026
National · Effective Oct 1, 2026
J6 · Effective Apr 1, 2026
National · Effective Aug 6, 2026
National · Effective Oct 1, 2026
National · Effective Jan 1, 2026
National · Effective Jan 1, 2026
National · Effective Apr 1, 2026
National · Effective Jan 1, 2026
National · Effective Jan 1, 2026
National · Effective Feb 1, 2026
| Palivizumab (Synagis) | Feb 15, 2024 | Covered |
|---|
| Polymerase Chain Reaction Testing: Selected Indications | Feb 9, 2024 | Covered |
|---|
| Positive Pressure Ventilation | Feb 16, 2024 | Covered |
|---|
| Pulse Oximetry and Capnography for Home Use | Nov 2, 2023 | Covered |
|---|
| Policy | Effective | Status of J45.998 |
|---|---|---|
| Pulmonary Function Testing | Not recorded | Covered |
| Policy | Effective | Status of J45.998 |
|---|---|---|
| Bronchial Thermoplasty | Jul 1, 2026 | Not covered |